USD 1.05
(-1.87%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.65 USD | -35.42% |
2022 | -0.48 USD | -220.0% |
2021 | -0.15 USD | -3160.87% |
2020 | -0.00 USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.09 USD | 77.64% |
2024 Q2 | -0.11 USD | -26.15% |
2023 Q1 | -0.09 USD | 99.79% |
2023 Q3 | -0.24 USD | -180.05% |
2023 FY | - USD | -35.42% |
2023 Q4 | -0.39 USD | -62.5% |
2023 Q2 | -0.09 USD | 5.72% |
2022 Q3 | -0.12 USD | 25.0% |
2022 FY | - USD | -220.0% |
2022 Q1 | -0.10 USD | 0.0% |
2022 Q4 | -43.86 USD | -36450.0% |
2022 Q2 | -0.16 USD | -60.0% |
2021 Q1 | -0.00 USD | 0.0% |
2021 FY | - USD | -3160.87% |
2020 FY | - USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Amgen Inc. | 12.56 USD | 105.175% |
AstraZeneca PLC | 1.92 USD | 133.854% |
Biogen Inc. | 8.02 USD | 108.105% |
Gilead Sciences, Inc. | 4.54 USD | 114.317% |
Scilex Holding Company | -1.28 USD | 49.219% |
Scilex Holding Company | -1.28 USD | 49.219% |